The Octopus Value Investing

Novo Nordisk - 2023 Earnings Review

The GLP-1 growth engine keeps working like a clockwork

The Octopus Value Investing

Sectors in briefSectors in brief

Jan 21, 2024

#2 Sectors in Brief - The Gaming Sector

A sector I don't invest in but its single exception

The Octopus Value Investing

The Octopus PortfolioThe Octopus Portfolio

Jan 14, 2024

#1 The Journey of Compounding - Introducing my portfolio

Portfolio presentation & review and 2023 recap

The Octopus Value Investing

Novo NordiskNovo Nordisk

Dec 17, 2023

#5 Novo Nordisk - The Other Side of the Story

Uncovering the potential weaknesess on the GLP-1 leader thesis

The Octopus Value Investing

Investment pillsInvestment pills

Dec 03, 2023

#2 Investment Pill | Domino's Pizza Nordic Black Swan

The unnoticed black swan of the American pizza franchise giant

The Octopus Value Investing

IntroductionIntroduction

Nov 26, 2023

#0 The Journey of Compouding - My Investment Phylosophy

The core principles behind my investment approach

The Octopus Value Investing

PandoraPandora

Nov 12, 2023

Pandora - Next Chapter for Growth?

Capital Markets Day, Q3 2023 earnings and thesis update

The Octopus Value Investing

Novo NordiskNovo Nordisk

Nov 05, 2023

#4 Novo Nordisk - Financials, Risks and Opportunities

Is the business quality backed by strong fundamentals?

The Octopus Value Investing

Novo NordiskNovo Nordisk

Oct 22, 2023

#3 Novo Nordisk - Management, subsidiaries and competence

Shedding light on some overlooked aspects of the company.

The Octopus Value Investing

Novo NordiskNovo Nordisk

Oct 15, 2023

#2 Novo Nordisk - Business breakdown

The business model behind the driving change in diabetes care

The Octopus Value Investing

Novo NordiskNovo Nordisk

Oct 01, 2023

# 1 Novo Nordisk - Changing diabetes

Introduction to diabetes, obesity andNovo Nordisk innovation for their treatment

The Octopus Value Investing

News & Trending TopicsNews & Trending Topics

Sep 17, 2023

Thoughts on Veralto - Danaher's spin-off

Why am I selling Veralto shares to buy more Danaher ones?

The Octopus Value Investing

First Back

1 2 3 4 5

Next Last

Archive

Novo Nordisk - 2023 Earnings Review

#2 Sectors in Brief - The Gaming Sector

#1 The Journey of Compounding - Introducing my portfolio

#5 Novo Nordisk - The Other Side of the Story

#2 Investment Pill | Domino's Pizza Nordic Black Swan

#0 The Journey of Compouding - My Investment Phylosophy

Pandora - Next Chapter for Growth?

#4 Novo Nordisk - Financials, Risks and Opportunities

#3 Novo Nordisk - Management, subsidiaries and competence

#2 Novo Nordisk - Business breakdown

# 1 Novo Nordisk - Changing diabetes

Thoughts on Veralto - Danaher's spin-off